US20010000798A1 - Intravascular flow modifier and reinforcement device - Google Patents

Intravascular flow modifier and reinforcement device Download PDF

Info

Publication number
US20010000798A1
US20010000798A1 US09/747,456 US74745600A US2001000798A1 US 20010000798 A1 US20010000798 A1 US 20010000798A1 US 74745600 A US74745600 A US 74745600A US 2001000798 A1 US2001000798 A1 US 2001000798A1
Authority
US
United States
Prior art keywords
loops
shape memory
wire
longitudinal sections
longitudinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/747,456
Other versions
US6416541B2 (en
Inventor
Andrew Denardo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/747,456 priority Critical patent/US6416541B2/en
Publication of US20010000798A1 publication Critical patent/US20010000798A1/en
Priority to US10/122,257 priority patent/US20020173839A1/en
Application granted granted Critical
Publication of US6416541B2 publication Critical patent/US6416541B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • A61F2/885Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils comprising a coil including a plurality of spiral or helical sections with alternate directions around a central axis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B21MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21FWORKING OR PROCESSING OF METAL WIRE
    • B21F45/00Wire-working in the manufacture of other particular articles
    • B21F45/008Wire-working in the manufacture of other particular articles of medical instruments, e.g. stents, corneal rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901Method of manufacturing prosthetic device

Definitions

  • the present invention relates to an intravascular flow modifier and reinforcement device for use within a body vessel, and more particularly, for a device to be used in combination with vasoocclusive devices placed in an aneurysm for the purpose of occluding an aneurysm, whereby the invention provides reinforcement for the area of the blood vessel in the vicinity of the aneurysm.
  • an aneurysm or other malformation is symptomatic of a general weakening of the vasculature in the area containing the aneurysm, and mere treatment of the aneurysm does not necessarily prevent a subsequent rupture in the surrounding area of the vessel.
  • Stents which are tubular reinforcements inserted into a blood vessel to provide an open path within the blood vessel, have been widely used in intravascular angioplasty treatment of occluded cardiac arteries.
  • the stent is inserted after an angioplasty procedure or the like in order to prevent restenosis of the artery.
  • the stents are often deployed by use of inflatable balloons, or mechanical devices which force the stent open, thereby reinforcing the artery wall in the clear through-path in the center of the artery after the angioplasty procedure to prevent restenosis.
  • the invention relates to a three-dimensional wire intravascular flow modifier which is formed of superelastic or shape memory material, which, in its deployed configuration comprises a series of circumferential loops connected by longitudinal portions proceeding in a multiple loop fashion from two free ends of the wire to a closed end loop of the wire.
  • the device Upon deployment, the device is placed within the vasculature so that it extends from a position proximal to a position distal of the aneurysm to be treated.
  • the device may be arranged so that an open portion of the loop straddles the neck of the aneurysm to allow placement of embolic coils and the like through the opening into the aneurysm.
  • the device Prior to placement, the device is deformed into a linear form and placed within a guiding catheter, which is used to position the distal end of the device so that the device is pushed out of the guiding catheter by means of a pusher and detached from the pusher by a variety of means to complete placement of the device. After placement of the device, the pusher and catheter are withdrawn.
  • a single piece of shape memory or superelastic alloys such as nickel titanium alloy, is wound over an essentially cylindrical mandrel into which are formed channels representing the progressive loop configuration of the invention.
  • the mandrel may be cylindrical with pegs inserted in positions representing transitions between the circumferential loops and the longitudinal portions of the wire.
  • a single wire is best wound progressively down the mandrel forming loops and longitudinal transitions until a desired length of the device is reached, at which point the path is retraced similarly to the position at which the device was begun on the mandrel.
  • the wire can then be heat treated on the mandrel to create a shape memory or treated to reach a superelastic state.
  • the device can be taken off of the mandrel and stretched to be inserted into a guiding catheter prior to insertion into the vasculature.
  • the configuration of the present invention provides important advantages over prior art devices in that it eliminates the necessity for balloon or mechanical placement devices which can cause unnecessary trauma to the delicate vasculature which has already been damaged by the presence of the aneurysm. For this reason, the invention is particularly useful to cover and reinforce large neck aneurysms.
  • the presence of the longitudinal portion of the coil dramatically improves the pushability of the device, thereby enhancing the ability to deploy and place the device within the vasculature, an issue of considerable importance if neither balloon nor mechanical placement methods are to be used.
  • the invention can be arranged in a variety of configurations which allow overlapping of the circumferential and longitudinal elements to create particularly desired characteristics to the device and the placement capabilities thereof.
  • the device may be configured so that a plurality of wires are used as described above to create more complex configurations and thereby enhance specific aspects of circumferential loop density or longitudinal portion pushability for various applications.
  • the density of loops can be varied from proximal to distal end in order to provide a relatively greater circumferential loop density in an area to be placed in a portion of the vasculature which is particularly weak or is threatened by treatment.
  • the device may be configured to have a variable diameter to the circumferential elements over the length of the device in order to provide relatively greater circumferential tension against the wall of the vessel in some areas than others.
  • Another advantage of the present invention is that it may be used in arteries up to renal size while still providing the benefits of placement without the use of balloons or mechanical expansions.
  • One significant benefit in such an application is that the flow through the vessel is never fully occluded by the placement of the device in the invention, and it is possible to place the device from a free flow guiding catheter that is relatively small in diameter compared to the inside diameter of the blood vessel being treated.
  • FIG. 1 is a perspective view of a deployed device configured according to the invention.
  • FIG. 2 is a side view of the deployed device of FIG. 1.
  • FIG. 3 is a plan view of a partially deployed device of the invention.
  • FIG. 4 is a side elevational view of the partially deployed device of FIG. 3.
  • FIG. 5 is a side elevational view of the device showing the deployment connector being released from the device.
  • FIG. 6 is a top elevational view of the device configured for installation in a guiding catheter.
  • FIG. 7 is a side elevational view of a deployed device illustrating a second preferred embodiment in which the coil of the device are more densely located in the desired portion of the stent.
  • FIG. 8 is an illustration of a mandrel upon which the device is formed in one preferred embodiment of the method of manufacture of the device.
  • the device of the present invention is designed to be deployed intravascularly without the necessity of balloons or other expansive elements and can be deployed from a guiding catheter directly into the area to be treated.
  • the intravascular device of the present invention is particularly useful for treatment of damaged arteries incorporating aneurysms and the like, particularly those which are treatable by the use of embolic coils or other embolic devices or agents used to occlude the aneurysm.
  • the device of the invention is particularly well adapted to use with the types of catheters used to place such embolic coils in aneurysms, and the device may be used to reinforce the area in the vicinity of the aneurysm while allowing placement of one or more embolic coils through the gaps in the stent, while assisting in the retention of the embolic devices within the dome of the aneurysm.
  • one presently preferred embodiment of the present invention 10 can be configured as a series of circumferential loops 12 connected by longitudinal connecting sections 14 to progressively form an essentially cylindrical intravascular device 10 out of a single loop of wire. More specifically, the device is configured of a single piece of wire in which the free ends are placed in close proximity and a first linear section 16 extends axially, and in which the linear wire sections 14 are parallel and longitudinal with the ultimate approximately cylindrical configuration of the device.
  • the wire is then formed into a pair of circumferential sections 12 extending in semi-circular arcs to a position in which a transition into a second pair of parallel elements 14 are formed for a second distance 18 at which they transition back to another pair of circumferential loops 12 and then proceeding sequentially in such a sequence towards an end loop 20 forming the end of the stent. While this configuration is described in the context of a wire, those skilled in the art will realize that other configurations of the material used to form the device, including foils and laminates, are within the scope of the invention.
  • the wire of the device is made of a superelastic material such as a nickel titanium alloy to allow for easy insertion of the device within the guiding catheter.
  • One material that is contemplated as a wire from which the device can be made is a stranded cable including one or more radiopaque strands, or which has radiopaque markers deployed along its length.
  • a stranded cable can be made of a variety of materials including stainless steel, shape memory alloy, superelastic alloy, platinum or the like or combinations thereof.
  • the invention provides numerous important advantages in the treatment of vascular malformations, and particularly malformations which include the presence of aneurysms. Since the device does not represent an essentially solid tubular member, and does not require the use of a balloon or other mechanical device for deployment, it is capable of deployment from a guiding catheter which need not occlude the artery as it is put into a position from which to deploy the device. Furthermore, the device upon deployment can reinforce the artery without occluding access to the aneurysm, thus allowing the device to be deployed prior to the placement of embolic coils or the like in the aneurysms.
  • the embolic coils or other embolic occlusive or other vasoocclusive devices can be placed and the device deployed thereafter to hold the devices in the aneurysm.
  • a variety of densities may be provided in the coil to coil distance, thus assisting in the treatment of different vascular malformations.
  • the present invention contains numerous advantages over the prior art, including enhanced pushability without creating circumferential stress from the loop section, as is often found in the case of coil-type intravascular flow modifiers known in the prior art. More specifically, the conformity of the device to the vascular walls is enhanced by the gaps in the loops 22 where the parallel sections are contained, and characteristics of the device such as loop strength and the resilience of the device are controlled by the radii 24 of the transitions to the longitudinal sections 14 the diameter of the wire and the distance between the parallel sections and the loops from which the device is formed. Thus, the invention provides a wide variety of performance characteristics that can be designed as part of the stent configuration.
  • the deployed device here illustrated in a side view, includes numerous longitudinal elements 14 and circumferential loops 12 , the spacing of which can be varied as described above.
  • the device prior to full deployment, can be made into an essentially flat configuration in which the free ends of the device are connected to the deployment device 26 on the distal end of a pusher 24 which fits within the guiding catheter (not shown).
  • the circumferential loops 12 are connected by the short linear transitions 14 between the loops which become essentially parallel with the longitudinal axis of the device in the deployed configuration.
  • FIG. 4 is an illustration of a partially deployed device in which the coils 12 have begun to assume their circumferential position within an artery.
  • FIG. 5 illustrates the detachment of the device 10 from the distal end of the pusher showing the device beginning to assume its final deployed position.
  • FIG. 6 illustrates the initial placement of the device 10 when made of superelastic or shape memory material in which it is first attached to the end of the pusher and the pusher is then pulled into the guiding catheter 30 , with the device assuming an essentially linear loop of wire that can then easily fit within the guiding catheter prior to deployment.
  • the pusher is used to extend the free end of the device from the guiding catheter in an area of the vasculature to be treated.
  • FIG. 7 illustrates one configuration of the device 10 of the present invention in which the device can be formed to have shorter connecting parallel sections 14 between the loops 12 and thus provide a higher degree of reinforcement in this specific area.
  • Such a configuration has numerous benefits depending on the topology of the damage to the artery, and can provide benefits for certain types of treatment therapies.
  • the present invention may be formed in a number of ways, but there are presently two preferred methods of manufacture.
  • a longitudinal mandrel 32 made of tungsten, ceramic or other heat resistant material has inserted into it pegs 34 of heat resistant material around which the wire to be formed into the device are wound.
  • the diameter of the pegs 36 and the spacing of the pegs 38 , 40 , 42 may be altered in order to provide certain characteristics that are desired in the stent as it is formed.
  • the mandrel can have a grooved configuration formed into it in which the wire is placed prior to heat treatment.
  • the present invention provides significant benefits to the treatment of vascular malformations, and particularly aneurysms in the neurovasculature.
  • the invention is particularly advantageous when used in combination with vasoocclusive devices placed in the aneurysm by intravascular procedures.

Abstract

An intravascular flow modifier and vascular reinforcement for treatment of aneurysms is formed of a single loop of wire formed into a series of transverse loops and longitudinal connecting sections to configure an essentially cylindrical reinforcement device that still allows, if desired, access to the neck of an aneurysm for insertion of embolic coils and the like.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The present invention relates to an intravascular flow modifier and reinforcement device for use within a body vessel, and more particularly, for a device to be used in combination with vasoocclusive devices placed in an aneurysm for the purpose of occluding an aneurysm, whereby the invention provides reinforcement for the area of the blood vessel in the vicinity of the aneurysm. [0002]
  • 2. Description of the Related Art [0003]
  • The progress of the medical arts related to treatment of vascular malformations has dramatically improved with the availability of intravascular devices capable of operating entirely within the vasculature. Thus, many highly invasive surgical procedures and inoperable conditions have been treated by the use of an expanding number of devices and procedures designed for those purposes. One particularly useful development in the medical arts has been the ability to treat defects in relatively small arteries and veins, such as those in the neurovascular system, by use of a guiding catheter and the placement of embolic coils and the like in areas where the malformation is likely to cause or has already caused a rupture in the blood vessel. More specifically, it has been found that the treatment of aneurysms by such devices and procedures allows the medical practitioner to avoid otherwise risky medical procedures. For example, when the placement of the defect is in the brain, a great deal of difficulty is presented to treatment of small defects in the blood vessels with conventional surgical techniques. For these reasons, the progress in development of devices to treat such defects has been encouraged and has produced useful results in a wide variety of patients. [0004]
  • One aspect of these surgical treatments is that an aneurysm or other malformation is symptomatic of a general weakening of the vasculature in the area containing the aneurysm, and mere treatment of the aneurysm does not necessarily prevent a subsequent rupture in the surrounding area of the vessel. Moreover, it is often desirable to provide a means to prevent the migration of the vasoocclusive devices, such as coils and the like, out of the aneurysm in the event that the aneurysm has a relatively large neck to dome ratio. [0005]
  • Stents, which are tubular reinforcements inserted into a blood vessel to provide an open path within the blood vessel, have been widely used in intravascular angioplasty treatment of occluded cardiac arteries. In such a case, the stent is inserted after an angioplasty procedure or the like in order to prevent restenosis of the artery. In these applications, the stents are often deployed by use of inflatable balloons, or mechanical devices which force the stent open, thereby reinforcing the artery wall in the clear through-path in the center of the artery after the angioplasty procedure to prevent restenosis. While such procedures may be useful in certain aspects of vascular surgery in which vasoocclusive devices are used, the weakness of the vasculature and the inaccessibility of the interior of the aneurysm from the vessel after the placement of such a stent, places limits on the applicability of such stents in procedures to repair aneurysms, particularly neuro-vascular aneurysms. Furthermore, the use of placement techniques, such as balloons or mechanical expansions of the type often found to be useful in cardiac surgery are relatively less useful in vasoocclusive surgery, particularly when tiny vessels, such as those found in the brain, are to be treated. For these reasons, it would be helpful if a device were available which was compatible with new techniques in vasoocclusive treatment of aneurysms and provides selective reinforcement in the vicinity of the artery, while avoiding any unnecessary trauma or risk of rupture to the blood vessel. The present invention provides these and other advantages. [0006]
  • SUMMARY OF THE INVENTION
  • Briefly, and in general terms, the invention relates to a three-dimensional wire intravascular flow modifier which is formed of superelastic or shape memory material, which, in its deployed configuration comprises a series of circumferential loops connected by longitudinal portions proceeding in a multiple loop fashion from two free ends of the wire to a closed end loop of the wire. Upon deployment, the device is placed within the vasculature so that it extends from a position proximal to a position distal of the aneurysm to be treated. The device may be arranged so that an open portion of the loop straddles the neck of the aneurysm to allow placement of embolic coils and the like through the opening into the aneurysm. Prior to placement, the device is deformed into a linear form and placed within a guiding catheter, which is used to position the distal end of the device so that the device is pushed out of the guiding catheter by means of a pusher and detached from the pusher by a variety of means to complete placement of the device. After placement of the device, the pusher and catheter are withdrawn. [0007]
  • In a presently preferred method of manufacture of the invention, a single piece of shape memory or superelastic alloys such as nickel titanium alloy, is wound over an essentially cylindrical mandrel into which are formed channels representing the progressive loop configuration of the invention. Alternatively, the mandrel may be cylindrical with pegs inserted in positions representing transitions between the circumferential loops and the longitudinal portions of the wire. A single wire is best wound progressively down the mandrel forming loops and longitudinal transitions until a desired length of the device is reached, at which point the path is retraced similarly to the position at which the device was begun on the mandrel. The wire can then be heat treated on the mandrel to create a shape memory or treated to reach a superelastic state. Thereafter, the device can be taken off of the mandrel and stretched to be inserted into a guiding catheter prior to insertion into the vasculature. The configuration of the present invention provides important advantages over prior art devices in that it eliminates the necessity for balloon or mechanical placement devices which can cause unnecessary trauma to the delicate vasculature which has already been damaged by the presence of the aneurysm. For this reason, the invention is particularly useful to cover and reinforce large neck aneurysms. The presence of the longitudinal portion of the coil dramatically improves the pushability of the device, thereby enhancing the ability to deploy and place the device within the vasculature, an issue of considerable importance if neither balloon nor mechanical placement methods are to be used. Furthermore, the invention can be arranged in a variety of configurations which allow overlapping of the circumferential and longitudinal elements to create particularly desired characteristics to the device and the placement capabilities thereof. [0008]
  • In a second presently preferred embodiment, the device may be configured so that a plurality of wires are used as described above to create more complex configurations and thereby enhance specific aspects of circumferential loop density or longitudinal portion pushability for various applications. Similarly, in another presently preferred embodiment, the density of loops can be varied from proximal to distal end in order to provide a relatively greater circumferential loop density in an area to be placed in a portion of the vasculature which is particularly weak or is threatened by treatment. In yet another presently preferred embodiment, the device may be configured to have a variable diameter to the circumferential elements over the length of the device in order to provide relatively greater circumferential tension against the wall of the vessel in some areas than others. [0009]
  • Another advantage of the present invention is that it may be used in arteries up to renal size while still providing the benefits of placement without the use of balloons or mechanical expansions. One significant benefit in such an application is that the flow through the vessel is never fully occluded by the placement of the device in the invention, and it is possible to place the device from a free flow guiding catheter that is relatively small in diameter compared to the inside diameter of the blood vessel being treated. [0010]
  • While certain features of the invention and its use have been described, it will be appreciated by those skilled in the art that many forms of the invention may be used for specific applications in the medical treatment of deformations of the vasculature. Other features and advantages of the present invention would become apparent from the following detailed description taken in conjunction with the accompanying drawings, which illustrate by way of example, the principles of the invention. [0011]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a deployed device configured according to the invention. [0012]
  • FIG. 2 is a side view of the deployed device of FIG. 1. [0013]
  • FIG. 3 is a plan view of a partially deployed device of the invention. [0014]
  • FIG. 4 is a side elevational view of the partially deployed device of FIG. 3. [0015]
  • FIG. 5 is a side elevational view of the device showing the deployment connector being released from the device. [0016]
  • FIG. 6 is a top elevational view of the device configured for installation in a guiding catheter. [0017]
  • FIG. 7 is a side elevational view of a deployed device illustrating a second preferred embodiment in which the coil of the device are more densely located in the desired portion of the stent. [0018]
  • FIG. 8 is an illustration of a mandrel upon which the device is formed in one preferred embodiment of the method of manufacture of the device. [0019]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • As shown in the exemplary drawings, which are provided for the purposes of illustration and not by way of limitation, the device of the present invention is designed to be deployed intravascularly without the necessity of balloons or other expansive elements and can be deployed from a guiding catheter directly into the area to be treated. The intravascular device of the present invention is particularly useful for treatment of damaged arteries incorporating aneurysms and the like, particularly those which are treatable by the use of embolic coils or other embolic devices or agents used to occlude the aneurysm. More particularly, the device of the invention is particularly well adapted to use with the types of catheters used to place such embolic coils in aneurysms, and the device may be used to reinforce the area in the vicinity of the aneurysm while allowing placement of one or more embolic coils through the gaps in the stent, while assisting in the retention of the embolic devices within the dome of the aneurysm. [0020]
  • As illustrated in FIG. 1, one presently preferred embodiment of the [0021] present invention 10 can be configured as a series of circumferential loops 12 connected by longitudinal connecting sections 14 to progressively form an essentially cylindrical intravascular device 10 out of a single loop of wire. More specifically, the device is configured of a single piece of wire in which the free ends are placed in close proximity and a first linear section 16 extends axially, and in which the linear wire sections 14 are parallel and longitudinal with the ultimate approximately cylindrical configuration of the device. The wire is then formed into a pair of circumferential sections 12 extending in semi-circular arcs to a position in which a transition into a second pair of parallel elements 14 are formed for a second distance 18 at which they transition back to another pair of circumferential loops 12 and then proceeding sequentially in such a sequence towards an end loop 20 forming the end of the stent. While this configuration is described in the context of a wire, those skilled in the art will realize that other configurations of the material used to form the device, including foils and laminates, are within the scope of the invention. In the presently preferred embodiment, the wire of the device is made of a superelastic material such as a nickel titanium alloy to allow for easy insertion of the device within the guiding catheter. Other materials, such as shape memory alloys, may also be used to provide for the dual purposes of ease of insertion into the guiding catheter and formation upon deployment into the desired shape of the device. One material that is contemplated as a wire from which the device can be made is a stranded cable including one or more radiopaque strands, or which has radiopaque markers deployed along its length. Such a stranded cable can be made of a variety of materials including stainless steel, shape memory alloy, superelastic alloy, platinum or the like or combinations thereof.
  • The invention provides numerous important advantages in the treatment of vascular malformations, and particularly malformations which include the presence of aneurysms. Since the device does not represent an essentially solid tubular member, and does not require the use of a balloon or other mechanical device for deployment, it is capable of deployment from a guiding catheter which need not occlude the artery as it is put into a position from which to deploy the device. Furthermore, the device upon deployment can reinforce the artery without occluding access to the aneurysm, thus allowing the device to be deployed prior to the placement of embolic coils or the like in the aneurysms. Alternatively, depending on the nature of the vascular defect, the embolic coils or other embolic occlusive or other vasoocclusive devices can be placed and the device deployed thereafter to hold the devices in the aneurysm. By use of the invention, a variety of densities may be provided in the coil to coil distance, thus assisting in the treatment of different vascular malformations. [0022]
  • The present invention contains numerous advantages over the prior art, including enhanced pushability without creating circumferential stress from the loop section, as is often found in the case of coil-type intravascular flow modifiers known in the prior art. More specifically, the conformity of the device to the vascular walls is enhanced by the gaps in the [0023] loops 22 where the parallel sections are contained, and characteristics of the device such as loop strength and the resilience of the device are controlled by the radii 24 of the transitions to the longitudinal sections 14 the diameter of the wire and the distance between the parallel sections and the loops from which the device is formed. Thus, the invention provides a wide variety of performance characteristics that can be designed as part of the stent configuration.
  • As shown in FIG. 2, the deployed device here illustrated in a side view, includes numerous [0024] longitudinal elements 14 and circumferential loops 12, the spacing of which can be varied as described above. As illustrated in FIG. 3, the device, prior to full deployment, can be made into an essentially flat configuration in which the free ends of the device are connected to the deployment device 26 on the distal end of a pusher 24 which fits within the guiding catheter (not shown). In this configuration, it can be seen that the circumferential loops 12 are connected by the short linear transitions 14 between the loops which become essentially parallel with the longitudinal axis of the device in the deployed configuration. FIG. 4 is an illustration of a partially deployed device in which the coils 12 have begun to assume their circumferential position within an artery. FIG. 5 illustrates the detachment of the device 10 from the distal end of the pusher showing the device beginning to assume its final deployed position.
  • FIG. 6 illustrates the initial placement of the [0025] device 10 when made of superelastic or shape memory material in which it is first attached to the end of the pusher and the pusher is then pulled into the guiding catheter 30, with the device assuming an essentially linear loop of wire that can then easily fit within the guiding catheter prior to deployment. Upon deployment, the pusher is used to extend the free end of the device from the guiding catheter in an area of the vasculature to be treated.
  • FIG. 7 illustrates one configuration of the [0026] device 10 of the present invention in which the device can be formed to have shorter connecting parallel sections 14 between the loops 12 and thus provide a higher degree of reinforcement in this specific area. Such a configuration has numerous benefits depending on the topology of the damage to the artery, and can provide benefits for certain types of treatment therapies.
  • The present invention may be formed in a number of ways, but there are presently two preferred methods of manufacture. In a first preferred method illustrated in FIG. 8, a [0027] longitudinal mandrel 32 made of tungsten, ceramic or other heat resistant material has inserted into it pegs 34 of heat resistant material around which the wire to be formed into the device are wound. The diameter of the pegs 36 and the spacing of the pegs 38, 40, 42 may be altered in order to provide certain characteristics that are desired in the stent as it is formed. Alternatively, the mandrel can have a grooved configuration formed into it in which the wire is placed prior to heat treatment.
  • From the above, it may be seen that the present invention provides significant benefits to the treatment of vascular malformations, and particularly aneurysms in the neurovasculature. Importantly, the invention is particularly advantageous when used in combination with vasoocclusive devices placed in the aneurysm by intravascular procedures. [0028]
  • It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims. [0029]

Claims (73)

I claim:
1. An intravascular flow modifier and vascular reinforcement device to be used in the intravascular treatment of blood vessels, comprising:
an elongate section of resilient material formed into a generally cylindrical device in which the two free ends are parallel to one another and extend distally from a proximal end of the device, thereafter transitioning at a first predetermined point to a first essentially circumferential loop for a distance less than half of the circumference of the device, thereafter transitioning to a longitudinal section of said wire for a predetermined length to a second predetermined point, thereafter transitioning to a second essentially circumferential loop and proceeding similarly to the distal end of the device.
2. The device of
claim 1
wherein said wire is made of a superelastic material.
3. The device of
claim 1
wherein said device is made of a shape memory material.
4. The device of
claim 2
, wherein the superelastic material is a nickel-titanium alloy.
5. The device of
claim 3
, wherein said shape memory material is a nickel titanium alloy.
6. The device of
claim 3
, wherein said shape memory material is a shape memory polymer.
7. The device of
claim 1
, wherein the free ends of the device are attached to deployment means at the distal end of a pusher for deploying said device in the vasculature of a patient.
8. The device of
claim 1
wherein the longitudinal sections of the wire from which the device is formed are parallel to one another and to the longitudinal axis of the device and are spaced apart by a predetermined distance.
9. The device of
claim 1
, wherein said circumferential loops are spaced apart distally along the device by a predetermined distance sufficient to allow passage of an embolic coil between said loops.
10. The device of
claim 1
, wherein said longitudinal sections are angled to one another to thereby provide an essentially trapezoidal opening in said device.
11. The device of
claim 1
wherein the lengths of said longitudinal sections are varied to vary the number of loops contained within a given length of the device.
12. The device of
claim 1
wherein the diameter of said loops is varied to allow said device to modify the blood flow characteristics in the vessel in which the device is placed.
13. The device of
claim 1
, wherein said loops are of different radii from one another.
14. The device of
claim 1
, wherein said device is formed of a length of material having a non-circular cross section.
15. The device of
claim 1
, wherein said circumferential loops are formed into an arcuate curve, the radius of said curve varying over the length of the loop.
16. The device of
claim 1
, wherein the transition to the circumferential loop to the longitudinal sections has a predetermined radius.
17. The device of
claim 1
, wherein the distal end of the device is a loop comprising a continuous loop extending from the most distal longitudinal sections.
18. The device of
claim 2
, wherein said wire is a stranded cable.
19. An intravascular flow modifier and vascular reinforcement device to be used in the treatment of vascular malformations, comprising;
a plurality of semi-circular loops formed from a long slender piece of resilient material, said resilient material being formed into a series of essentially longitudinal sections between said loops, said longitudinal section connecting said semi-circular loops, said longitudinal sections including radii at the transitions between said longitudinal sections and said semi-circular loops, said longitudinal sections and said semi-circular loops proceeding distally from a proximal point to the distal end of said device, whereby said semi-circular loops and said longitudinal elements combine to form an essentially cylindrical reinforcement for use in a damaged portion of the vasculature.
20. The device of
claim 18
wherein said wire is made of a superelastic material.
21. The device of
claim 18
wherein said device is made of a shape memory material.
22. The device of
claim 18
, wherein the superelastic material is a nickel-titanium alloy.
23. The device of
claim 18
, wherein said shape memory material is a nickel titanium alloy.
24. The device of
claim 18
, wherein said shape memory material is a shape memory polymer.
25. The device of
claim 19
, wherein said long slender piece of resilient material is a stranded cable.
26. The device of
claim 25
, wherein said stranded cable comprises at least one strand of superelastic material.
27. The device of
claim 19
, wherein the free ends of the device are attached to deployment means at the distal end of a pusher for deploying said device in the vasculature of a patient.
28. The device of
claim 19
wherein the longitudinal sections of the wire from which the device is formed are parallel to one another and to the longitudinal axis of the device and are spaced apart by a predetermined distance.
29. The device of
claim 19
, wherein said circumferential loops are spaced apart distally along the device by a predetermined distance sufficient to allow passage of an embolic coil between said loops.
30. The device of
claim 19
, wherein said longitudinal sections are angled to one another to thereby provide an essentially trapezoidal opening in said device.
31. The device of
claim 19
wherein the lengths of said longitudinal sections are varied to vary the number of loops contained within a given length of the device.
32. The device of
claim 19
wherein the diameter of said loops is varied to allow said device to modify the blood flow characteristics in the vessel in which the device is placed.
33. The device of
claim 19
, wherein said loops are of different radii from one another.
34. The device of
claim 19
, wherein said device is formed of a length of material having a non-circular cross section.
35. The device of
claim 19
, wherein said circumferential loops are formed into an arcuate curve, the radius of said curve varying over the length of the loop.
36. The device of
claim 19
, wherein the transition to the circumferential loop to the longitudinal sections has a predetermined radius.
37. The device of
claim 19
, wherein the distal end of the device is a loop comprising a continuous loop extending from the most distal longitudinal sections.
38. An intravascular flow modifier and vascular reinforcement to be used in the treatment of aneurysms, comprising:
a plurality of pairs of longitudinal elements connecting semi-circular loops, the loops and longitudinal sections being formed of a single wire, progressing from a pair of longitudinal elements proximal to the device and extending distally to define an essentially cylindrical reinforcement;
said longitudinal elements spaced apart and said cylindrical elements spaced apart to provide openings through which a vasoocclusive device or material can be introduced from an area inside said device to an area outside this said device and within an aneurysm to be treated, said device being capable of being formed into an essentially linear configuration for insertion into a guiding catheter, and:
a release means at the proximal end of said device attaching said device to a pusher within the catheter and which may be used to push the device out of the catheter when the catheter has reached a predetermined position within the vasculature.
39. The device of
claim 38
wherein said wire is made of a superelastic material.
40. The device of
claim 38
wherein said device is made of a shape memory material.
41. The device of
claim 38
, wherein the superelastic material is a nickel-titanium alloy.
42. The device of
claim 38
, wherein said shape memory material is a nickel titanium alloy.
43. The device of
claim 38
, wherein said shape memory material is a shape memory polymer.
44. The device of
claim 38
, wherein the free ends of the device are attached to deployment means at the distal end of a pusher for deploying said device in the vasculature of a patient.
45. The device of
claim 38
wherein the longitudinal sections of the wire from which the device is formed are parallel to one another and to the longitudinal axis of the device and are spaced apart by a predetermined distance.
46. The device of
claim 38
, wherein said circumferential loops are spaced apart distally along the device by a predetermined distance sufficient to allow passage of an embolic coil between said loops.
47. The device of
claim 38
, wherein said longitudinal sections are angled to one another to thereby provide an essentially trapezoidal opening in said device.
48. The device of
claim 38
wherein the lengths of said longitudinal sections are varied to vary the number of loops contained within a given length of the device.
49. The device of
claim 38
wherein the diameter of said loops is varied to allow said device to modify the blood flow characteristics in the vessel in which the device is placed.
50. The device of
claim 38
, wherein said loops are of different radii from one another.
51. The device of
claim 38
, wherein said device is formed of a length of material having a non-circular cross section.
52. The device of
claim 38
, wherein said device is formed from a multistranded cable.
53. The device of
claim 52
, wherein said multistranded cable includes at least one strand made of a nickel-titanium alloy.
54. The device of
claim 38
, wherein said circumferential loops are formed into an arcuate curve, the radius of said curve varying over the length of the loop.
55. The device of
claim 38
, wherein the transition to the circumferential loop to the longitudinal sections has a predetermined radius.
56. The device of
claim 38
, wherein the distal end of the device is a loop comprising a continuous loop extending from the most distal longitudinal sections.
57. A method of manufacturing an intravascular flow modifier and reinforcement device for use in the treatment of aneurysms, comprising:
forming a mandrel of heat resistant material into an essentially cylindrical shape representing the interior diameter of the device to be formed;
inserting into said mandrel a series of pegs projecting from the surface of the mandrel and representing the transition points between semi-circular loop portions of the device and longitudinal portions of the device;
winding a wire about said pegs from a proximal position to a distal position and back to a proximal position to thereby form a device containing semi-circular loops and longitudinal portions and to form an essentially cylindrical device; and
heat treating said device to a predetermined temperature to provide desired material characteristics.
58. The device of
claim 57
wherein said wire is made of a superelastic material.
59. The device of
claim 57
wherein said device is made of a shape memory material.
60. The device of
claim 57
, wherein the superelastic material is a nickel-titanium alloy.
61. The device of
claim 57
, wherein said shape memory material is a nickel titanium alloy.
62. The device of
claim 57
, wherein said shape memory material is a shape memory polymer.
63. The device of
claim 57
, wherein said wire is a stranded cable.
64. The device of
claim 63
, wherein said stranded cable includes at least one strand of a nickel-titanium alloy.
65. The device of
claim 57
, wherein the free ends of the device are attached to deployment means at the distal end of a pusher for deploying said device in the vasculature of a patient.
66. A method of manufacture for a device to use as an intravascular flow modifier and aneurysm treatment comprising:
forming an essentially cylindrical mandrel, the outside diameter of which represents the outside diameter of the device;
forming grooves in the mandrel that are approximately the depth of the wire to be used in fabricating the device and which represent the pattern of semi-circular loops and longitudinal elements of the device;
winding a wire element into the grooves to form the pattern of semicircular loops and longitudinal elements comprising the configuration of the device; and
heat treating the wire to obtain a desired combination of resilience and flexibility.
67. The device of
claim 66
wherein said wire is made of a multistranded cable.
68. The device of
claim 66
wherein said wire is a superelastic material.
69. The device of
claim 59
wherein said device is made of a shape memory material.
70. The device of
claim 66
, wherein the superelastic material is a nickel-titanium alloy.
71. The device of
claim 66
, wherein said shape memory material is a nickel titanium alloy.
72. The device of
claim 66
, wherein said shape memory material is a shape memory polymer.
73. The device of
claim 66
, wherein the free ends of the device are attached to deployment means at the distal end of a pusher for deploying said device in the vasculature of a patient.
US09/747,456 1998-07-24 2000-12-22 Intravascular flow modifier and reinforcement device Expired - Lifetime US6416541B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/747,456 US6416541B2 (en) 1998-07-24 2000-12-22 Intravascular flow modifier and reinforcement device
US10/122,257 US20020173839A1 (en) 1998-07-24 2002-04-12 Intravascular flow modifier and reinforcement device with connected segments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/122,243 US6165194A (en) 1998-07-24 1998-07-24 Intravascular flow modifier and reinforcement device
US09/747,456 US6416541B2 (en) 1998-07-24 2000-12-22 Intravascular flow modifier and reinforcement device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/122,243 Division US6165194A (en) 1998-07-24 1998-07-24 Intravascular flow modifier and reinforcement device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/122,257 Continuation-In-Part US20020173839A1 (en) 1998-07-24 2002-04-12 Intravascular flow modifier and reinforcement device with connected segments

Publications (2)

Publication Number Publication Date
US20010000798A1 true US20010000798A1 (en) 2001-05-03
US6416541B2 US6416541B2 (en) 2002-07-09

Family

ID=22401547

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/122,243 Expired - Lifetime US6165194A (en) 1998-07-24 1998-07-24 Intravascular flow modifier and reinforcement device
US09/747,456 Expired - Lifetime US6416541B2 (en) 1998-07-24 2000-12-22 Intravascular flow modifier and reinforcement device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/122,243 Expired - Lifetime US6165194A (en) 1998-07-24 1998-07-24 Intravascular flow modifier and reinforcement device

Country Status (7)

Country Link
US (2) US6165194A (en)
EP (1) EP1143878B1 (en)
JP (1) JP2002521088A (en)
AT (1) ATE324842T1 (en)
AU (1) AU5214799A (en)
DE (1) DE69931189D1 (en)
WO (1) WO2000004845A2 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
WO2014201434A3 (en) * 2013-06-14 2015-10-29 Artventive Medical Group, Inc. Implantable luminal devices
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9451965B2 (en) 2010-06-29 2016-09-27 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10004513B2 (en) 2013-02-05 2018-06-26 Artventive Medical Group, Inc. Bodily lumen occlusion
US20180193176A1 (en) * 2009-11-16 2018-07-12 Tre' Raymond Welch Stent and method for manufacturing thereof
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US11464657B2 (en) 2019-11-22 2022-10-11 Tré Raymond Welch Stent and method of manufacture

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040130599A1 (en) * 1997-07-15 2004-07-08 Silverbrook Research Pty Ltd Ink jet printhead with amorphous ceramic chamber
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US20020173839A1 (en) * 1998-07-24 2002-11-21 Leopold Eric W. Intravascular flow modifier and reinforcement device with connected segments
US6656218B1 (en) * 1998-07-24 2003-12-02 Micrus Corporation Intravascular flow modifier and reinforcement device
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6613074B1 (en) * 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6214016B1 (en) * 1999-04-29 2001-04-10 Medtronic, Inc. Medical instrument positioning device internal to a catheter or lead and method of use
US6559845B1 (en) * 1999-06-11 2003-05-06 Pulse Entertainment Three dimensional animation system and method
US7033374B2 (en) * 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7029486B2 (en) 2000-09-26 2006-04-18 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6605101B1 (en) 2000-09-26 2003-08-12 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US6656221B2 (en) * 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
WO2002062263A2 (en) 2001-02-05 2002-08-15 Viacor, Inc. Apparatus and method for reducing mitral regurgitation
CA2668308A1 (en) * 2001-03-05 2002-12-05 Viacor, Incorporated Apparatus and method for reducing mitral regurgitation
WO2002076284A2 (en) * 2001-03-23 2002-10-03 Viacor, Inc. Method and apparatus for reducing mitral regurgitation
US7186264B2 (en) * 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) * 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US20030078654A1 (en) * 2001-08-14 2003-04-24 Taylor Daniel C. Method and apparatus for improving mitral valve function
US7052487B2 (en) * 2001-10-26 2006-05-30 Cohn William E Method and apparatus for reducing mitral regurgitation
JP4109627B2 (en) * 2001-11-07 2008-07-02 マイクロ ベンション インコーポレイテッド Microcoil vascular occlusion device with multi-axis secondary shape
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US6953473B2 (en) * 2001-12-20 2005-10-11 Boston Scientific Scimed, Inc. Detachable device with electrically responsive element
US7125420B2 (en) * 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US20040034405A1 (en) * 2002-07-26 2004-02-19 Dickson Andrew M. Axially expanding polymer stent
US7598224B2 (en) * 2002-08-20 2009-10-06 Biosurface Engineering Technologies, Inc. Dual chain synthetic heparin-binding growth factor analogs
US8227411B2 (en) 2002-08-20 2012-07-24 BioSurface Engineering Technologies, Incle FGF growth factor analogs
US7481821B2 (en) * 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040153025A1 (en) * 2003-02-03 2004-08-05 Seifert Paul S. Systems and methods of de-endothelialization
US7744583B2 (en) 2003-02-03 2010-06-29 Boston Scientific Scimed Systems and methods of de-endothelialization
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
US20040193141A1 (en) * 2003-02-14 2004-09-30 Leopold Eric W. Intravascular flow modifier and reinforcement device and deployment system for same
US20050015110A1 (en) 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
CA2533556A1 (en) * 2003-07-23 2005-02-03 Viacor, Inc. Method and apparatus for improving mitral valve function
US8014849B2 (en) * 2003-11-21 2011-09-06 Stryker Corporation Rotational markers
DE602005023714D1 (en) 2004-02-20 2010-11-04 Biosurface Eng Tech Inc BONE MORPHOGENETIC PROTEIN-2 POSITIVE MODULATOR (BMP-2)
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
KR101300437B1 (en) 2004-05-25 2013-08-26 코비디엔 엘피 Vascular stenting for aneurysms
US8147534B2 (en) 2005-05-25 2012-04-03 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
DE502004010411D1 (en) 2004-09-22 2009-12-31 Dendron Gmbh DEVICE FOR IMPLANTING MICROWAVES
ES2321300T3 (en) 2004-09-22 2009-06-04 Dendron Gmbh MEDICAL IMPLANT
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
CN101415449A (en) * 2006-04-06 2009-04-22 雷瓦医药公司 Embolism prosthesis for treating vas aneurysm
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
WO2007121405A2 (en) 2006-04-17 2007-10-25 Micro Therapeutics, Inc. System and method for mechanically positioning intravascular implants
JP2009541358A (en) 2006-06-22 2009-11-26 バイオサーフェス エンジニアリング テクノロジーズ,インク. Compositions and methods for delivering a BMP-2 amplification factor / co-activator to enhance bone formation
CN103767810B (en) 2006-10-22 2016-06-15 Idev科技公司 From the manufacturing process of extendable bracket
KR20100015521A (en) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 An implant, a mandrel, and a method of forming an implant
WO2008112435A2 (en) 2007-03-13 2008-09-18 Micro Therapeutics, Inc. An implant including a coil and a stretch-resistant member
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US8968382B2 (en) 2007-12-11 2015-03-03 Cornell University Method and apparatus for restricting flow through an opening in the side wall
CN101945624A (en) 2007-12-11 2011-01-12 康奈尔大学 Method and apparatus for sealing an opening in the side wall of a body lumen
US8623071B2 (en) * 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US20090318948A1 (en) * 2008-04-22 2009-12-24 Coherex Medical, Inc. Device, system and method for aneurysm embolization
EP3045123B1 (en) 2008-06-16 2020-04-08 University Of Rochester Compositions comprising a combination of fibroblast growth factor (fgf) analogs with thrombopoietin for use for treating acute radiation syndrome
US9402707B2 (en) 2008-07-22 2016-08-02 Neuravi Limited Clot capture systems and associated methods
US8777976B2 (en) 2008-07-22 2014-07-15 Neuravi Limited Clot capture systems and associated methods
AU2010206960A1 (en) 2009-01-22 2011-08-11 Cornell University Method and apparatus for restricting flow through the wall of a lumen
US20120083819A1 (en) * 2010-10-04 2012-04-05 Frank Wang External scaffolds for expanding strictures in tubular organs and their use
US9463036B2 (en) 2010-10-22 2016-10-11 Neuravi Limited Clot engagement and removal system
WO2012120490A2 (en) 2011-03-09 2012-09-13 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
US11259824B2 (en) 2011-03-09 2022-03-01 Neuravi Limited Clot retrieval device for removing occlusive clot from a blood vessel
EP2693981A4 (en) 2011-04-01 2015-07-01 Univ Cornell Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
CA2835427A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
US9579104B2 (en) 2011-11-30 2017-02-28 Covidien Lp Positioning and detaching implants
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9173753B1 (en) 2012-05-11 2015-11-03 W. L. Gore & Associates, Inc. System and method for forming an endoluminal device
US20150297238A1 (en) * 2012-08-19 2015-10-22 Christopher G.M. Ken Geometric coil
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US20140180326A1 (en) * 2012-12-20 2014-06-26 Empire Technology Development Llc Inflatable balloon for protecting blood vessel
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9642635B2 (en) 2013-03-13 2017-05-09 Neuravi Limited Clot removal device
US9433429B2 (en) 2013-03-14 2016-09-06 Neuravi Limited Clot retrieval devices
SI2967610T1 (en) 2013-03-14 2019-07-31 Neuravi Limited A clot retrieval device for removing occlusive clot from a blood vessel
TR201901830T4 (en) 2013-03-14 2019-03-21 Neuravi Ltd Devices and methods for the removal of acute blockages from blood vessels.
CN108186074A (en) * 2014-02-27 2018-06-22 因库麦迪斯有限公司 For treating the framework microcoils of vascular diseases
US10285720B2 (en) 2014-03-11 2019-05-14 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US10792056B2 (en) 2014-06-13 2020-10-06 Neuravi Limited Devices and methods for removal of acute blockages from blood vessels
EP3154452A1 (en) 2014-06-13 2017-04-19 Neuravi Limited Devices for removal of acute blockages from blood vessels
US10265086B2 (en) 2014-06-30 2019-04-23 Neuravi Limited System for removing a clot from a blood vessel
US11253278B2 (en) 2014-11-26 2022-02-22 Neuravi Limited Clot retrieval system for removing occlusive clot from a blood vessel
JP2017535352A (en) 2014-11-26 2017-11-30 ニューラヴィ・リミテッド Clot collection device for removing obstructive clots from blood vessels
US10617435B2 (en) 2014-11-26 2020-04-14 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques
KR102457315B1 (en) 2016-08-17 2022-10-24 뉴라비 리미티드 A thrombus recovery system to remove an occlusive thrombus from a blood vessel
MX2019002565A (en) 2016-09-06 2019-09-18 Neuravi Ltd A clot retrieval device for removing occlusive clot from a blood vessel.
CN110267627B (en) 2016-12-09 2023-07-11 真复灵公司 Systems, devices, and methods for accurately deploying implants in the prostatic urethra
AU2018306738A1 (en) * 2017-07-28 2020-02-13 Zenflow, Inc. Systems, devices, and methods for expanding the diameter of the prostatic urethra
US20210137711A1 (en) * 2018-03-30 2021-05-13 Kurume University Stent
US10842498B2 (en) 2018-09-13 2020-11-24 Neuravi Limited Systems and methods of restoring perfusion to a vessel
US11406416B2 (en) 2018-10-02 2022-08-09 Neuravi Limited Joint assembly for vasculature obstruction capture device
WO2020101009A1 (en) * 2018-11-16 2020-05-22 川澄化学工業株式会社 Tubular treatment tool skeleton, and tubular treatment tool
ES2910600T3 (en) 2019-03-04 2022-05-12 Neuravi Ltd Powered Clot Recovery Catheter
JP2021041169A (en) 2019-09-11 2021-03-18 ニューラヴィ・リミテッド Expandable mouth catheter
US11712231B2 (en) 2019-10-29 2023-08-01 Neuravi Limited Proximal locking assembly design for dual stent mechanical thrombectomy device
US11890213B2 (en) 2019-11-19 2024-02-06 Zenflow, Inc. Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra
US11839725B2 (en) 2019-11-27 2023-12-12 Neuravi Limited Clot retrieval device with outer sheath and inner catheter
US11779364B2 (en) 2019-11-27 2023-10-10 Neuravi Limited Actuated expandable mouth thrombectomy catheter
US11517340B2 (en) 2019-12-03 2022-12-06 Neuravi Limited Stentriever devices for removing an occlusive clot from a vessel and methods thereof
US11944327B2 (en) 2020-03-05 2024-04-02 Neuravi Limited Expandable mouth aspirating clot retrieval catheter
US11633198B2 (en) 2020-03-05 2023-04-25 Neuravi Limited Catheter proximal joint
US11883043B2 (en) 2020-03-31 2024-01-30 DePuy Synthes Products, Inc. Catheter funnel extension
US11759217B2 (en) 2020-04-07 2023-09-19 Neuravi Limited Catheter tubular support
US11730501B2 (en) 2020-04-17 2023-08-22 Neuravi Limited Floating clot retrieval device for removing clots from a blood vessel
US11871946B2 (en) 2020-04-17 2024-01-16 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11717308B2 (en) 2020-04-17 2023-08-08 Neuravi Limited Clot retrieval device for removing heterogeneous clots from a blood vessel
US11737771B2 (en) 2020-06-18 2023-08-29 Neuravi Limited Dual channel thrombectomy device
US11937836B2 (en) 2020-06-22 2024-03-26 Neuravi Limited Clot retrieval system with expandable clot engaging framework
US11395669B2 (en) 2020-06-23 2022-07-26 Neuravi Limited Clot retrieval device with flexible collapsible frame
US11439418B2 (en) 2020-06-23 2022-09-13 Neuravi Limited Clot retrieval device for removing clot from a blood vessel
US11864781B2 (en) 2020-09-23 2024-01-09 Neuravi Limited Rotating frame thrombectomy device
US11937837B2 (en) 2020-12-29 2024-03-26 Neuravi Limited Fibrin rich / soft clot mechanical thrombectomy device
US11872354B2 (en) 2021-02-24 2024-01-16 Neuravi Limited Flexible catheter shaft frame with seam
US11937839B2 (en) 2021-09-28 2024-03-26 Neuravi Limited Catheter with electrically actuated expandable mouth

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1667730A (en) * 1928-05-01 of chicago
US1341052A (en) * 1916-06-15 1920-05-25 Francis G Gale Chain
FR592182A (en) 1924-03-24 1925-07-28 Urethral probe
US2078182A (en) * 1935-08-09 1937-04-20 Sirian Wire And Contact Compan Tungsten manufacture
US2549335A (en) * 1947-04-18 1951-04-17 Rahthus Max Ornamental chain
US3334629A (en) * 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
US3649224A (en) * 1968-04-18 1972-03-14 Sylvania Electric Prod Method of making nonsag filaments for electric lamps
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
GB2066839B (en) 1979-12-29 1984-03-14 Vysoka Skola Chem Tech Method of manufacture of perfumed detergents
AT392733B (en) * 1981-09-16 1991-05-27 Medinvent Sa DEVICE FOR TREATING BLOOD VESSELS OR THE LIKE.
SE445884B (en) * 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4638803A (en) * 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
US4494531A (en) * 1982-12-06 1985-01-22 Cook, Incorporated Expandable blood clot filter
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4670286A (en) * 1983-09-20 1987-06-02 Allied Corporation Method of forming prosthetic devices
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US4611594A (en) * 1984-04-11 1986-09-16 Northwestern University Medical instrument for containment and removal of calculi
JPS6198254A (en) 1984-10-19 1986-05-16 ザ・ベントリー―ハリス・マニュファクチュアリング・カンパニー Prosthetic stent
US5037377A (en) * 1984-11-28 1991-08-06 Medtronic, Inc. Means for improving biocompatibility of implants, particularly of vascular grafts
US4718907A (en) * 1985-06-20 1988-01-12 Atrium Medical Corporation Vascular prosthesis having fluorinated coating with varying F/C ratio
US4748986A (en) * 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
EP0556940A1 (en) * 1986-02-24 1993-08-25 Robert E. Fischell Intravascular stent
SE453258B (en) * 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
US5527336A (en) 1986-12-09 1996-06-18 Boston Scientific Corporation Flow obstruction treatment method
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4813925A (en) * 1987-04-21 1989-03-21 Medical Engineering Corporation Spiral ureteral stent
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4850960A (en) * 1987-07-08 1989-07-25 Joseph Grayzel Diagonally tapered, bevelled tip introducing catheter and sheath and method for insertion
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
FR2632864B2 (en) * 1987-12-31 1990-10-19 Biomat Sarl ANTI-EMBOLIC ELASTIC FILTERING SYSTEM FOR CELLAR VEIN AND ASSEMBLY OF MEANS FOR ITS PLACEMENT
JP2561853B2 (en) * 1988-01-28 1996-12-11 株式会社ジェイ・エム・エス Shaped memory molded article and method of using the same
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5226913A (en) * 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5176661A (en) * 1988-09-06 1993-01-05 Advanced Cardiovascular Systems, Inc. Composite vascular catheter
US4957479A (en) * 1988-10-17 1990-09-18 Vance Products Incorporated Indwelling ureteral stent placement apparatus
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5203772A (en) * 1989-01-09 1993-04-20 Pilot Cardiovascular Systems, Inc. Steerable medical device
US4856516A (en) * 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US4990155A (en) * 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5171262A (en) * 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
EP0408245B1 (en) * 1989-07-13 1994-03-02 American Medical Systems, Inc. Stent placement instrument
IE73670B1 (en) * 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
DE4102550A1 (en) 1990-02-02 1991-08-08 Stephan Prof Dr Bockenheimer Sealing blood vessel fistula - involves inserted sleeve with spiral support with turns bridged by impervious elastic material
DK0441516T3 (en) * 1990-02-08 1995-06-12 Howmedica Inflatable catheter
US5186992A (en) * 1990-03-12 1993-02-16 The Bentley-Harris Manufacturing Company Braided product and method of making same
US5569245A (en) 1990-03-13 1996-10-29 The Regents Of The University Of California Detachable endovascular occlusion device activated by alternating electric current
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5108407A (en) * 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
US5064435A (en) * 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5041084A (en) * 1990-08-09 1991-08-20 Dlp, Inc. Single stage venous catheter
US5139480A (en) * 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
US5163952A (en) * 1990-09-14 1992-11-17 Michael Froix Expandable polymeric stent with memory and delivery apparatus and method
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
US5176625A (en) * 1990-10-25 1993-01-05 Brisson A Glen Stent for ureter
US5160341A (en) * 1990-11-08 1992-11-03 Advanced Surgical Intervention, Inc. Resorbable urethral stent and apparatus for its insertion
US5133731A (en) * 1990-11-09 1992-07-28 Catheter Research, Inc. Embolus supply system and method
US5217483A (en) * 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
CS277367B6 (en) * 1990-12-29 1993-01-13 Krajicek Milan Three-layered vascular prosthesis
US5135536A (en) * 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5116365A (en) * 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5228453A (en) * 1991-05-07 1993-07-20 Target Therapeutics, Inc. Catheter guide wire
US5304200A (en) * 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5314472A (en) * 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
USD359802S (en) 1991-06-28 1995-06-27 Cook Incorporated Vascular stent
US5141502A (en) * 1991-08-28 1992-08-25 Macaluso Jr Joseph N Ureteral stent
US5183085A (en) * 1991-09-27 1993-02-02 Hans Timmermans Method and apparatus for compressing a stent prior to insertion
US5443498A (en) * 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5304194A (en) * 1991-10-02 1994-04-19 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5226911A (en) * 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5500013A (en) * 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5151105A (en) * 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5354309A (en) * 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5256146A (en) * 1991-10-11 1993-10-26 W. D. Ensminger Vascular catheterization system with catheter anchoring feature
ATE157525T1 (en) * 1991-10-11 1997-09-15 Angiomed Ag DEVICE FOR EXPANDING A STENOSIS
US5456713A (en) * 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
US5234437A (en) * 1991-12-12 1993-08-10 Target Therapeutics, Inc. Detachable pusher-vasoocclusion coil assembly with threaded coupling
US5261916A (en) * 1991-12-12 1993-11-16 Target Therapeutics Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling
US5258042A (en) * 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5484449A (en) * 1992-01-07 1996-01-16 Medtronic, Inc. Temporary support for a body lumen and method
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
GR920100104A (en) * 1992-03-13 1993-11-30 Christodoulos I Stefanadis Temporary luminal stent for the support of the vascular wall.
US5222969A (en) * 1992-03-16 1993-06-29 Rolando Gillis Intravascular stent for cardiovascular intervention
WO1995014500A1 (en) * 1992-05-01 1995-06-01 Beth Israel Hospital A stent
US5540712A (en) * 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5643339A (en) 1992-08-06 1997-07-01 William Cook Europe A/S Prosthetic device for sustaining a blood-vessel or hollow organ lumen
US5443478A (en) * 1992-09-02 1995-08-22 Board Of Regents, The University Of Texas System Multi-element intravascular occlusion device
US5350397A (en) * 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
US5250071A (en) * 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5312415A (en) * 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5322501A (en) * 1992-10-02 1994-06-21 Mahmud Durrani Ayaz Continent urethral stent for treating and preventing urethral stricture after surgery
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5690666A (en) 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
FR2699809B1 (en) * 1992-12-28 1995-02-17 Celsa Lg Device which can selectively constitute a temporary blood filter.
US5336205A (en) * 1993-02-25 1994-08-09 Target Therapeutics, Inc. Flow directed catheter
SG85682A1 (en) * 1993-03-11 2002-01-15 Medinol Ltd Stent
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material
IL105828A (en) 1993-05-28 1999-06-20 Medinol Ltd Medical stent
EP0627201B1 (en) 1993-06-02 1998-07-22 Schneider (Europe) GmbH Device for releasing a self-expanding endoprosthesis
DE4334140C2 (en) 1993-10-07 1996-04-18 Angiomed Ag Stent and device with stent
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5476505A (en) * 1993-11-18 1995-12-19 Advanced Cardiovascular Systems, Inc. Coiled stent and delivery system
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5441516A (en) * 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
IL108832A (en) 1994-03-03 1999-12-31 Medinol Ltd Urological stent and deployment device therefor
JP2735393B2 (en) 1994-03-03 1998-04-02 ターゲット セラピュウティクス,インコーポレイテッド Method and apparatus for detecting disconnection of intravascular embolization device
US5549663A (en) 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
US5415664A (en) * 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
CA2188563C (en) 1994-04-29 2005-08-02 Andrew W. Buirge Stent with collagen
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5540701A (en) 1994-05-20 1996-07-30 Hugh Sharkey Passive fixation anastomosis method and device
US5549624A (en) 1994-06-24 1996-08-27 Target Therapeutics, Inc. Fibered vasooclusion coils
US5522836A (en) 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5653726A (en) 1994-11-03 1997-08-05 Archimedes Surgical, Inc. Retrograde dissector and method for facilitating a TRAM flap
US5549662A (en) 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5690671A (en) 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5674277A (en) 1994-12-23 1997-10-07 Willy Rusch Ag Stent for placement in a body tube
DK175166B1 (en) 1995-01-03 2004-06-21 Cook William Europ Method of manufacturing an assembly for placing an embolization coil in the vascular system and such assembly as well as an apparatus for advancing the assembly
US5514176A (en) * 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
DE19508805C2 (en) 1995-03-06 2000-03-30 Lutz Freitag Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions
CA2171896C (en) 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US5613981A (en) 1995-04-21 1997-03-25 Medtronic, Inc. Bidirectional dual sinusoidal helix stent
US5639277A (en) 1995-04-28 1997-06-17 Target Therapeutics, Inc. Embolic coils with offset helical and twisted helical shapes
US5624461A (en) 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
NO962336L (en) 1995-06-06 1996-12-09 Target Therapeutics Inc Vaso-occlusive spiral
US5582619A (en) 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5749918A (en) 1995-07-20 1998-05-12 Endotex Interventional Systems, Inc. Intraluminal graft and method for inserting the same
US5713907A (en) 1995-07-20 1998-02-03 Endotex Interventional Systems, Inc. Apparatus and method for dilating a lumen and for inserting an intraluminal graft
US5749883A (en) 1995-08-30 1998-05-12 Halpern; David Marcos Medical instrument
DK171865B1 (en) * 1995-09-11 1997-07-21 Cook William Europ Expandable endovascular stent
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5690643A (en) 1996-02-20 1997-11-25 Leocor, Incorporated Stent delivery system
US5649949A (en) 1996-03-14 1997-07-22 Target Therapeutics, Inc. Variable cross-section conical vasoocclusive coils
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5733329A (en) 1996-12-30 1998-03-31 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US5830229A (en) 1997-03-07 1998-11-03 Micro Therapeutics Inc. Hoop stent
US5824053A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5824059A (en) 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
US6203731B1 (en) * 1997-10-17 2001-03-20 Tohoku Munekata Company Limited Method for injection molding of plastic products having excellent transcription properties

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10786373B2 (en) * 2009-11-16 2020-09-29 Tre' Raymond Welch Stent and method for manufacturing thereof
US20180193176A1 (en) * 2009-11-16 2018-07-12 Tre' Raymond Welch Stent and method for manufacturing thereof
US9451965B2 (en) 2010-06-29 2016-09-27 Artventive Medical Group, Inc. Reducing flow through a tubular structure
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9737307B2 (en) 2013-02-05 2017-08-22 Artventive Medical Group, Inc. Blood vessel occlusion
US10004513B2 (en) 2013-02-05 2018-06-26 Artventive Medical Group, Inc. Bodily lumen occlusion
US9107669B2 (en) 2013-02-05 2015-08-18 Artventive Medical Group, Inc. Blood vessel occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
WO2014201434A3 (en) * 2013-06-14 2015-10-29 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US10441290B2 (en) 2013-06-14 2019-10-15 Artventive Medical Group, Inc. Implantable luminal devices
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US11224438B2 (en) 2014-05-01 2022-01-18 Artventive Medical Group, Inc. Treatment of incompetent vessels
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US11464657B2 (en) 2019-11-22 2022-10-11 Tré Raymond Welch Stent and method of manufacture

Also Published As

Publication number Publication date
ATE324842T1 (en) 2006-06-15
AU5214799A (en) 2000-02-14
WO2000004845A3 (en) 2001-10-25
EP1143878B1 (en) 2006-05-03
US6416541B2 (en) 2002-07-09
DE69931189D1 (en) 2006-06-08
WO2000004845A2 (en) 2000-02-03
EP1143878A2 (en) 2001-10-17
JP2002521088A (en) 2002-07-16
US6165194A (en) 2000-12-26
EP1143878A3 (en) 2002-09-11

Similar Documents

Publication Publication Date Title
US6165194A (en) Intravascular flow modifier and reinforcement device
US8398700B2 (en) Intravascular flow modifier and reinforcement device and deployment system for same
US20020173839A1 (en) Intravascular flow modifier and reinforcement device with connected segments
US6913618B2 (en) Intravascular flow modifier and reinforcement device
US9855047B2 (en) Flexible vascular occluding device
AU774515B2 (en) Occlusive coil manufacture and delivery
US20060206201A1 (en) Flexible vascular occluding device
JP2002523125A (en) Vaso-occlusive coil
JP2008515467A (en) Vascular occlusion device with embolic mesh ribbon
US20070270902A1 (en) Thin Film Metallic Devices for Plugging Aneurysms or Vessels
JP2009533083A (en) System and method for occluding an aneurysm
WO2023038724A1 (en) Vaso-occlusive device
AU2013201605A1 (en) Flexible vascular occluding device

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 12